Pacer BioThreat Strategy ETF
VIRS
VIRS was delisted on the 10th of October, 2024.
6 hedge funds and large institutions have $1.87M invested in Pacer BioThreat Strategy ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
4% more capital invested
Capital invested by funds: $1.79M → $1.87M (+$78.5K)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$57.7K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.5K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.96K |
| 4 |
Morgan Stanley
New York
|
+$36 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$11.1K |
| 2 |
AF
Allworth Financial
Folsom,
California
|
-$4.82K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $775K | +$21.5K | +602 | +3% |
|
|
IAIM
2
International Assets Investment Management
Orlando,
Florida
| $667K | -$11.1K | -310 | -2% |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $327K | +$1.96K | +55 | +0.6% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $94K | +$57.7K | +1,619 | +167% |
|
5
UBS Group
Zurich,
Switzerland
| $3.05K | – | – | – |
|
|
6
Morgan Stanley
New York
| $48 | +$36 | +1 | New |
|
|
AF
7
Allworth Financial
Folsom,
California
| – | -$4.82K | -133 | Closed |
|
VIRS Hedge Fund Activity: Q2 2024 in Review
6 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q2 2024, worth a combined $1.87M — up 4.4% from $1.79M a quarter earlier.
Fund positioning in VIRS was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $57.7K. The largest seller was International Assets Investment Management, cutting an estimated $11.1K.
- 6 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $1.87M of Pacer BioThreat Strategy ETF stock for Q2 2024, up 4.4% quarter-over-quarter.
- 1 fund opened new Pacer BioThreat Strategy ETF positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Pacer BioThreat Strategy ETF buyer in Q2 2024 was Royal Bank of Canada, an estimated $57.7K added.
- The largest Pacer BioThreat Strategy ETF seller in Q2 2024 was International Assets Investment Management, an estimated $11.1K sold.
Based on aggregated 13F filings for Q2 2024.